nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AML evolution from preleukemia to leukemia and relapse
|
Shlush, Liran I. |
|
2015 |
|
2-3 |
p. 81-89 9 p. |
artikel |
2 |
Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia
|
Advani, Anjali |
|
2015 |
|
2-3 |
p. 116-123 8 p. |
artikel |
3 |
Editorial Board / Aims & Scope
|
|
|
2015 |
|
2-3 |
p. iii- 1 p. |
artikel |
4 |
Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease
|
Appelbaum, Frederick R. |
|
2015 |
|
2-3 |
p. 133-140 8 p. |
artikel |
5 |
IDH2 inhibition in AML: Finally progress?
|
Stein, Eytan M. |
|
2015 |
|
2-3 |
p. 112-115 4 p. |
artikel |
6 |
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia
|
Falini, Brunangelo |
|
2015 |
|
2-3 |
p. 90-97 8 p. |
artikel |
7 |
Index
|
|
|
2015 |
|
2-3 |
p. I- 1 p. |
artikel |
8 |
Is there a best graft source of transplantation in acute myeloid leukemia?
|
Ballen, Karen K. |
|
2015 |
|
2-3 |
p. 147-154 8 p. |
artikel |
9 |
Is there a role for therapy after transplant?
|
Oran, Betül |
|
2015 |
|
2-3 |
p. 124-132 9 p. |
artikel |
10 |
Plasticity of hematopoietic stem cells
|
Ogawa, Makio |
|
2015 |
|
2-3 |
p. 73-80 8 p. |
artikel |
11 |
Reasons for optimism in the therapy of acute leukemia
|
Rowe, Jacob M. |
|
2015 |
|
2-3 |
p. 69-72 4 p. |
artikel |
12 |
Recent developments in HLA-haploidentical transplantations
|
Showel, Margaret |
|
2015 |
|
2-3 |
p. 141-146 6 p. |
artikel |
13 |
Role of intestinal microbiota in transplantation outcomes
|
Taur, Ying |
|
2015 |
|
2-3 |
p. 155-161 7 p. |
artikel |
14 |
Should minimal residual disease guide therapy in AML?
|
Paietta, Elisabeth |
|
2015 |
|
2-3 |
p. 98-105 8 p. |
artikel |
15 |
Should older adults with AML receive post-remission therapy?
|
Stone, Richard M. |
|
2015 |
|
2-3 |
p. 106-111 6 p. |
artikel |